16 - 20 February 2025
San Diego, California, US

This conference will address digital and computational pathology, from acquisition of pathology data to its management, analysis, and interpretation by observers. With the recent advances in whole slide scanners and novel instrumentation for multispectral, multiparametric tissue imaging the use of digital pathology data is growing in importance. Both the pre-clinical and clinical modeling of disease states are addressed by the developing field of computational pathology. The evolving concepts of human intelligence-artificial intelligence interactions in our understanding of image data are foundational in computational pathology. There is evidence that digital and computational pathology can improve diagnosis and grading of cancer and other pathology tasks, but there are still limitations and challenges that must be addressed before it can be fully incorporated into the clinical workflow.

Although there has been great progress in the development and application of computational pathology methods over recent years, there are several significant computational challenges specific to pathology imaging that distinguish it from its radiological counterpart. There are also unique challenges in terms of how digitized pathology specimens and correlated data are presented to, modified and interpreted by clinicians and computers.

We invite submissions that address specific problems related to image acquisition, display, interpretation, computer-aided diagnosis, and quantitative image analysis of pathology specimens. We particularly welcome contributions that identify and address challenges encountered in digital pathology imaging as well as in new approaches for image capture and analysis. Suggested topics include:

Image acquisition, storage, and display

Quantitative image analysis

Information fusion

Digital/computational pathology and the pathologist

 


POSTER AWARD
The Digital and Computational Pathology conference will feature a cum laude poster award. All posters displayed at the meeting for this conference are eligible. Posters will be evaluated at the meeting by the awards committee. The winners will be announced during the conference and the presenting author will be recognized and awarded a certificate.

;
In progress – view active session
Conference MI109

Digital and Computational Pathology

This conference has an open call for papers:
Abstract Due: 7 August 2024
Author Notification: 28 October 2024
Manuscript Due: 29 January 2025

This conference will address digital and computational pathology, from acquisition of pathology data to its management, analysis, and interpretation by observers. With the recent advances in whole slide scanners and novel instrumentation for multispectral, multiparametric tissue imaging the use of digital pathology data is growing in importance. Both the pre-clinical and clinical modeling of disease states are addressed by the developing field of computational pathology. The evolving concepts of human intelligence-artificial intelligence interactions in our understanding of image data are foundational in computational pathology. There is evidence that digital and computational pathology can improve diagnosis and grading of cancer and other pathology tasks, but there are still limitations and challenges that must be addressed before it can be fully incorporated into the clinical workflow.

Although there has been great progress in the development and application of computational pathology methods over recent years, there are several significant computational challenges specific to pathology imaging that distinguish it from its radiological counterpart. There are also unique challenges in terms of how digitized pathology specimens and correlated data are presented to, modified and interpreted by clinicians and computers.

We invite submissions that address specific problems related to image acquisition, display, interpretation, computer-aided diagnosis, and quantitative image analysis of pathology specimens. We particularly welcome contributions that identify and address challenges encountered in digital pathology imaging as well as in new approaches for image capture and analysis. Suggested topics include:

Image acquisition, storage, and display

  • acquisition, storage, display and processing of digital microscopy images
  • image mosaicking of nontraditional near-real-time microscopy (OCT, confocal)
  • multispectral imaging
  • high-dimensional multiplexed staining and imaging of tissues
  • multi-focus volume imaging
  • compression
  • methodologies for the objective technical assessment of digital pathology systems including color calibration
  • whole slide imaging
  • strategies for data storage and remote processing.

Quantitative image analysis

  • computer-aided diagnosis, prognosis and predictive analysis
  • automated quantification of tissue biomarkers
  • grading and classification of pathology images
  • segmentation of cellular and tissue structures
  • shape analysis and morphology in pathology imaging
  • architectural feature extraction and quantification
  • multispectral- and volume-based segmentation
  • content-based image retrieval
  • high-performance computing for whole-slide tissue image analysis
  • multi-stain and multiplexed image analysis
  • correlative microscopy
  • understanding of image data across scale
  • machine learning trends in digital pathology: handcrafted features versus deep learning.

Information fusion

  • radiology-pathology registration and fusion
  • registration of multiple stained tissue microscopy images
  • integration of digital image features with 'omics' data for fused diagnostics.

Digital/computational pathology and the pathologist

  • observer performance, human factors, reading strategies, and diagnostic interpretation issues
  • remote consultation
  • metrics, variability and standardization issues unique to digital pathology
  • methodologies for the objective technical assessment of digital pathology systems
  • optical probe tracking and visualization tools
  • PACS and new DICOM standards for histopathology
  • making the case for clinical digital pathology systems in pathology practice.

 


POSTER AWARD
The Digital and Computational Pathology conference will feature a cum laude poster award. All posters displayed at the meeting for this conference are eligible. Posters will be evaluated at the meeting by the awards committee. The winners will be announced during the conference and the presenting author will be recognized and awarded a certificate.

Conference Chair
Univ. at Buffalo (United States)
Conference Chair
The Univ. of Western Ontario (Canada)
Program Committee
Bilkent Univ. (Turkey)
Program Committee
Univ. of Michigan Health System (United States)
Program Committee
Univ. of Illinois at Urbana-Champaign (United States)
Program Committee
Institut für Angewandte Informatik e.V. (Germany)
Program Committee
The Univ. of Texas Health Science Ctr. at San Antonio (United States)
Program Committee
London Health Sciences Ctr. (Canada)
Program Committee
Penn State College of Medicine (United States)
Program Committee
U.S. Food and Drug Administration (United States)
Program Committee
NEC Labs. America, Inc. (United States)
Program Committee
Rutgers, The State Univ. of New Jersey (United States)
Program Committee
Emory Univ. (United States)
Program Committee
The Univ. of Pennsylvania Health System (United States)
Program Committee
AstraZeneca Pharmaceuticals LP (United States)
Program Committee
Toronto Metropolitan Univ. (Canada)
Program Committee
Radboud Univ. Medical Ctr. (Netherlands)
Program Committee
Emory Univ. School of Medicine (United States)
Program Committee
Barco N.V. (Belgium)
Program Committee
Univ. of California, Davis (United States)
Program Committee
Univ. de Caen Basse-Normandie (France)
Program Committee
Radboud Univ. Medical Ctr. (Netherlands)
Program Committee
Emory Univ. School of Medicine (United States)
Program Committee
Univ. of Leeds (United Kingdom)
Program Committee
The Univ. of New South Wales (Australia)
Program Committee
Inspirata, Inc. (United States)
Program Committee
McMaster Univ. (Canada)
Program Committee
Lawrence Berkeley National Lab. (United States)
Program Committee
The Univ. of Warwick (United Kingdom)
Program Committee
U.S. Food and Drug Administration (United States)
Program Committee
Univ. of Florida College of Medicine (United States)
Program Committee
Amazon Lab126 (United States)
Program Committee
Univ. of Leeds (United Kingdom)
Program Committee
Technische Univ. Eindhoven (Netherlands)
Program Committee
Sunnybrook Research Institute (Canada)
Program Committee
Rensselaer Polytechnic Institute (United States)
Additional Information

View call for papers


What you will need to submit

  • Presentation title
  • Author(s) information
  • Speaker biography (1000-character max including spaces)
  • Abstract for technical review (200-300 words; text only)
  • Summary of abstract for display in the program (50-150 words; text only)
  • Keywords used in search for your paper (optional)
  • Two- to four-page (not counting acknowledgements and references) supplemental file, prepared as a PDF formatted to SPIE manuscript specifications, that includes:
    • Paper title
    • Authors
    • Description of purpose
    • Method(s)
    • Results
    • Supporting images/tables/figures
    • Conclusions
    • Any new or breakthrough work to be presented
    • Whether the work is being, or has been, submitted for publication or presentation elsewhere, and, if so, indicate how the submissions differ.

Note: Only original material should be submitted. Commercial papers, papers with no new research/development content, and papers with proprietary restrictions will not be accepted for presentation.